Nika Pharmaceuticals, Inc (NIKA) Operating Expenses (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Operating Expenses came in at $10143.0 in Q3 2023, up 60.01% YoY from $6339.0 in Q3 2022, and down 63.52% on a QoQ basis from $27806.0 in Q2 2023.
Nika Pharmaceuticals, Inc (NIKA) Operating Expenses (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Operating Expenses data on file, last reported at $10143.0 in Q3 2023.
- Quarterly Operating Expenses rose 60.01% year-over-year to $10143.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $57519.0 (down 98.19% YoY) and the FY2022 annual result came in at $3.2 million, up 21540.26% from the prior year.
- Operating Expenses retreated to $10143.0 in Q3 2023, from $27806.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $3.2 million in Q2 2022 to a low of $2699.0 in Q3 2021.
- A 3-year average of $295995.1 and a median of $6339.0 in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 106557.99% — and 2023, when it plunged 99.12%.
- Tracing NIKA's Operating Expenses over 3 years: stood at $3300.0 in 2021, then surged by 356.06% to $15050.0 in 2022, then tumbled by 32.6% to $10143.0 in 2023.
- The last three Operating Expenses figures came in at $10143.0 (Q3 2023), $27806.0 (Q2 2023), and $19570.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10,143.00 |
| Jun 30, 2023 | 27,806.00 |
| Mar 31, 2023 | 19,570.00 |
| Dec 31, 2022 | 15,050.00 |
| Sep 30, 2022 | 6,339.00 |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 6,316.00 |
| Dec 31, 2021 | 3,300.00 |
| Sep 30, 2021 | 2,699.00 |
| Jun 30, 2021 | 2,959.00 |
| Mar 31, 2021 | 5,754.00 |